Ultrasonic-Assisted Fabrication of MIL-100(Fe) Metal–Organic Frameworks as a Carrier for the Controlled Delivery of the Chloroquine Drug

Metal–organic framework materials (MOFs) are materials with an ordered crystalline structure and high porosity that have been intensively investigated for many applications, such as gas adsorption, catalysis, sensors, drug delivery, and so on. Among them, the MOF-based drug delivery system has received increasing interest from scientists worldwide. This work presented the preparation of the MIL-100(Fe) metal–organic framework from the organic ligand of trimesic acid and iron ions with ultrasonic assistance. Scanning electron microscopy (SEM), Brunauer–Emmett–Teller surface area (BET), X-ray diffraction (XRD), infrared spectroscopy (FTIR), and Raman spectroscopy were employed to characterize the prepared MIL-100(Fe) material. MIL-100(Fe) materials synthesized by the ultrasonic method have uniform particle morphology ranging from 100 to 300 nm with a surface area of 1033 m2/g. The prepared MIL-100(Fe) was employed as a carrier for delivering chloroquine drug with a maximal loading capacity of 220 mg/g. The MIL-100(Fe)@chloroquine system was also characterized in detail. The delivery system’s slow drug release was studied, showing that nearly 80% of chloroquine molecules were released after 7.5 h of immersing time in PBS and simulated gastric solutions and completely detached from the MIL-100(Fe)@chloroquine system only after approximately 80 h. This result shows the ability to control chloroquine drug release of the material, reducing the possibility of drug shock.

[1]  S. Pandey,et al.  UiO-66 metal-organic framework nanoparticles as gifted MOFs to the biomedical application: A comprehensive review , 2022, Journal of Drug Delivery Science and Technology.

[2]  S. Mallakpour,et al.  Application of MOF materials as drug delivery systems for cancer therapy and dermal treatment , 2022, Coordination Chemistry Reviews.

[3]  Mahmoud Elsabahy,et al.  Intratracheal Administration of Chloroquine-Loaded Niosomes Minimize Systemic Drug Exposure , 2021, Pharmaceutics.

[4]  Li Zhang,et al.  Titanium-based metal-organic frameworks as potential chloroquine drug carriers , 2021 .

[5]  Shing-Jyh Chang,et al.  Advances in Functional Metal‐Organic Frameworks Based On‐Demand Drug Delivery Systems for Tumor Therapeutics , 2021, Advanced NanoBiomed Research.

[6]  U. S. Arrozi,et al.  Fabrication of composite materials MIL-100(Fe)/Indonesian activated natural zeolite as enhanced CO2 capture material , 2021, Chemical Papers.

[7]  A. Boguszewska-Czubara,et al.  Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects-In Vivo and In Vitro. , 2020, ACS applied materials & interfaces.

[8]  M. Sillanpää,et al.  Hydrothermal synthesis of novel MIL-100(Fe)@SBA-15 composite material with high adsorption efficiency towards dye pollutants for wastewater remediation , 2020 .

[9]  S. Jeong,et al.  Highly Porous MIL-100(Fe) for the Hydrogen Evolution Reaction (HER) in Acidic and Basic Media , 2020, ACS omega.

[10]  M. Alhumaimess,et al.  Metal–organic frameworks and their catalytic applications , 2020 .

[11]  Wu Zhong,et al.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro , 2020, Cell Discovery.

[12]  Sharon Einav,et al.  A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 , 2020, Journal of Critical Care.

[13]  K. Titov,et al.  Green Reconstruction of MIL-100 (Fe) in Water for High Crystallinity and Enhanced Guest Encapsulation , 2020, ACS Sustainable Chemistry & Engineering.

[14]  S. Ismadji,et al.  Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery , 2019, Scientific Reports.

[15]  Meral Turabik,et al.  Comparison of MIL-101(Fe) and amine-functionalized MIL-101(Fe) as photocatalysts for the removal of imidacloprid in aqueous solution , 2019, Journal of the Iranian Chemical Society.

[16]  Siamak Javanbakht,et al.  Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system. , 2019, Carbohydrate polymers.

[17]  D. La,et al.  Size-Control and Surface Modification of Flexible Metal-Organic Framework MIL-53(Fe) by Polyethyleneglycol for 5- Fluorouracil Anticancer Drug Delivery , 2019, ChemistrySelect.

[18]  B. Yan,et al.  A new Dy(III)-based metal-organic framework with polar pores for pH-controlled anticancer drug delivery and inhibiting human osteosarcoma cells , 2019, Journal of Coordination Chemistry.

[19]  Jianyong Zhang,et al.  Applications of Porous Metal–Organic Framework MIL-100(M) (M = Cr, Fe, Sc, Al, V) , 2018, Crystal Growth & Design.

[20]  M. Ferrari,et al.  Chloroquine and nanoparticle drug delivery: A promising combination , 2018, Pharmacology & therapeutics.

[21]  Hai-Lei Cao,et al.  Synthesis of Metal–Organic Framework Materials by Reflux: A Faster and Greener Pathway to Achieve Super-Hydrophobicity and Photocatalytic Application , 2018, Crystal Growth & Design.

[22]  V. Zeleňák,et al.  Metal-organic framework MIL-101(Fe)-NH 2 functionalized with different long-chain polyamines as drug delivery system , 2018, Inorganic Chemistry Communications.

[23]  G. Nagaraju,et al.  Targeting autophagy in gastrointestinal malignancy by using nanomaterials as drug delivery systems. , 2018, Cancer letters.

[24]  Xia Li,et al.  New insights into the degradation mechanism of metal-organic frameworks drug carriers , 2017, Scientific Reports.

[25]  C. Serre,et al.  In vivo behavior of MIL-100 nanoparticles at early times after intravenous administration. , 2016, International journal of pharmaceutics.

[26]  Lin Mei,et al.  The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug. , 2014, Biomaterials.

[27]  D. Browning Hydroxychloroquine and Chloroquine Retinopathy , 2014 .

[28]  Fumin Zhang,et al.  Synthesis of MIL-100(Fe) at Low Temperature and Atmospheric Pressure , 2013 .

[29]  Ana E. Platero‐Prats,et al.  Green Microwave Synthesis of MIL‐100(Al, Cr, Fe) Nanoparticles for Thin‐Film Elaboration , 2012 .

[30]  Sabyasachi Das,et al.  Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: a dose and duration dependent approach. , 2012, International journal of pharmaceutics.

[31]  J. Lee,et al.  Large scale fluorine-free synthesis of hierarchically porous iron(III) trimesate MIL-100(Fe) with a zeolite MTN topology , 2012 .

[32]  Demin Liu,et al.  Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. , 2011, Accounts of chemical research.

[33]  C. Serre,et al.  Infrared study of the influence of reducible iron(III) metal sites on the adsorption of CO, CO2, propane, propene and propyne in the mesoporous metal-organic framework MIL-100. , 2011, Physical chemistry chemical physics : PCCP.

[34]  Gérard Férey,et al.  BioMOFs: metal-organic frameworks for biological and medical applications. , 2010, Angewandte Chemie.

[35]  Christian Serre,et al.  Biodegradable therapeutic MOFs for the delivery of bioactive molecules. , 2010, Chemical communications.

[36]  Gérard Férey,et al.  Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.

[37]  Omar K Farha,et al.  Metal-organic framework materials as catalysts. , 2009, Chemical Society reviews.

[38]  Gérard Férey,et al.  Flexible porous metal-organic frameworks for a controlled drug delivery. , 2008, Journal of the American Chemical Society.

[39]  C. Serre,et al.  Microwave Synthesis of Chromium Terephthalate MIL‐101 and Its Benzene Sorption Ability , 2007 .

[40]  L. Tilley,et al.  Prospects for the treatment of drug-resistant malaria parasites , 2006, Future microbiology.

[41]  R. Atilla,et al.  Massive hydroxychloroquine overdose , 2004, Acta anaesthesiologica Scandinavica.

[42]  T. Albertson,et al.  Treatment of hydroxychloroquine overdose. , 2001, The American journal of emergency medicine.

[43]  D. Furst Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases , 1996, Lupus.